Hiscox (LON:HSX - Get Free Report) had its target price raised by stock analysts at Citigroup from GBX 1,611 to GBX 1,846 in a research report issued to clients and investors on Thursday,London Stock Exchange reports. The firm currently has a "neutral" rating on the stock. Citigroup's price target would indicate a potential upside of 1.99% from the stock's previous close.
Several other equities analysts have also commented on the stock. Peel Hunt restated an "add" rating and issued a GBX 1,960 target price on shares of Hiscox in a research report on Wednesday. Jefferies Financial Group reaffirmed an "underperform" rating and set a GBX 1,148 price target on shares of Hiscox in a report on Thursday, May 7th. Royal Bank Of Canada reiterated an "outperform" rating and set a GBX 1,850 price target on shares of Hiscox in a research report on Wednesday, June 24th. JPMorgan Chase & Co. boosted their price objective on shares of Hiscox from GBX 1,800 to GBX 2,050 and gave the company an "overweight" rating in a research report on Friday, July 10th. Finally, Berenberg Bank upped their target price on Hiscox from GBX 1,760 to GBX 1,900 and gave the stock a "buy" rating in a research note on Friday, May 8th. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of GBX 1,802.43.
Check Out Our Latest Analysis on Hiscox
Hiscox Stock Up 1.1%
HSX opened at GBX 1,810 on Thursday. Hiscox has a twelve month low of GBX 1,257.18 and a twelve month high of GBX 1,966.44. The company has a 50-day simple moving average of GBX 1,809.90 and a 200 day simple moving average of GBX 1,644.75. The stock has a market capitalization of £5.81 billion, a price-to-earnings ratio of 10.34, a P/E/G ratio of -2.30 and a beta of 0.40.
Hiscox Company Profile
(
Get Free Report)
Hiscox is a global, specialty insurer, listed on the London Stock Exchange and headquartered in Bermuda. We have grown from
our roots as a niche Lloyd's of London underwriter into a diversified international insurance group operating across direct‑to‑consumer, broker and partner‑distributed retail insurance; large and complex commercial insurance; reinsurance and insurance‑linked strategies.
We currently employ over 3,000 people worldwide across 13 countries and 31 offices. We have a distinctive brand, energised and ambitious teams, a strong balance sheet, and plenty of room to grow in each of our chosen markets and lines of business.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Hiscox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hiscox wasn't on the list.
While Hiscox currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.